SAGE

Resources for the Comprehensive Geriatric Assessment based

Proactive and Personalised Primary Care of the Elderly

Self Administered Gerocognitive Exam

Purpose : Detect early signs of cognitive (memory or thinking) impairments.Accurately identify early symptoms of Alzheimer’s and dementia

Admin time : 10-15 min

User Friendly : High

Administered by : Healthcare provider or self administered

Content : The SAGE test measures :

Orientation (month, date, and year)
Language (verbal fluency and picture naming)
Reasoning and simple math skills
Visuospatial orientation
Executive function
Memory

Author : Scharre D, 2007 The Ohio State University Wexner Medical Center

Free to use

Translations: SAGE is available in other languages, including English (US) and English (New Zealand)

access

SAGE (Eng. UK) Test Form 1

SAGE (Eng. UK) Test Form 2

SAGE (Eng. UK) Test Form 3

SAGE (Eng. UK) Test Form 4

SAGE

Advantages:

Quick
Accurate
Self-administered
Four different examples to choose between. Seniors could take the test annually for four years without any need to repeat the questions. This reduces the chance of people practicing the same test multiple times and giving remembered answers
Available in several other languages.

Disadvantages:

Cannot be self-scored immediately after completion. Requires doctor scoring and interpretation in clinical context.

Accuracy :

Sensitivity : 95%, specificity 79% (Scharre DW, 2010)

SAGE compares favorably with the Mini-Mental State Exam (MMSE), a standard exam for testing cognitive ability that must be administered by someone else.

In terms of accuracy in diagnosing dementia, the SAGE test has higher sensitivity than the MMSE (95% vs. 90%) as well as higher specificity (79% vs. 71%). (Scharre DW, 2010)

SAGE compares favorably with the Montreal Cognitive Assessment (MoCA), a standard exam for testing cognitive ability that must be administered by someone else.

In terms of accuracy in diagnosing dementia, the SAGE test has higher sensitivity than the MMSE (95% vs. 91%) as well as higher specificity (79% vs. 67%). (Scharre DW, 2017)

This Tool is used in Dementia

Back To : Dementia